Stall Courant and Diagonal Bio agree to a pilot test of LAMPlify®
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) ("Diagonal Bio" or "the Company") and Stall Courant, owned by Unibet founder Anders Ström and run by trotting trainer Sabine Kagebrant, have signed an agreement regarding a three-month pilot test of the LAMPlify®…
Diagonal Bio AB’s rights issue of units oversubscribed
English, IR, MAR, News, RegulatoryThe subscription period in Diagonal Bio AB’s ("Diagonal Bio" or the "Company") rights issue of units of initially approximately SEK 6.0 million ended on 6 February 2025 (the "Rights Issue"). The Rights Issue was subscribed to a total of…
Stall Goop conducts pilot test of LAMPlify®
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) ("Diagonal Bio" or "the Company") has signed an agreement with Stall Goop regarding a pilot test of LAMPlify®. The three-month pilot test, starting in February 2025, aims to enhance equine health and performance…
Diagonal Bio announces positive pilot test results and secures order from StallZet
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) ("Diagonal Bio" or the "Company") announces an order valued at approximately SEK 150,000 from Daniel Redén, a renowned horse trainer at StallZet. The order comes as a result of the successful completion of…
Diagonal Bio expands its testing panel for horses with EHV-5 detection
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) ("Diagonal Bio" or the "Company") announces the expansion of its equine diagnostic testing panel to include the detection of Equine Herpesvirus type 5 (EHV-5), following the recommendation of Daniel Redén –…
The Board of Directors of Diagonal Bio AB resolves on a directed issue of units and a rights issue of units to focus on validation of LAMPlify®’s commercial interest
IR, MAR, News, Regulatory, SwedishBoard of Directors of Diagonal Bio AB (”Diagonal Bio” or the ”Company”) has today resolved on a directed issue of units consisting of shares and consideration free warrants of series TO 2, of initially approximately SEK…
Diagonal Bio enters into a strategic partnership with Daniel Redén at StallZet to enhance commercialisation plans
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces that Daniel Redén, a renowned horse trainer at StallZet, has entered into a partnership with Diagonal Bio and will act as a marketing partner for the Company to enhance…
Renowned horse race jockey and trainer conducts pilot test of LAMPlify®
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces that one of Sweden’s most accomplished horse race trainers, Madeleine Smith, has initiated a six-month pilot test of LAMPlify®. The pilot test will focus on enhancing…
Diagonal Bio announces pilot test with LAMPlify® at Kolgjini Stables
English, IR, MAR, News, RegulatoryDiagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces a partnership with Kolgjini Stables (Stall Kolgjini), founded by renowned harness racer Lutfi Kolgjini, to conduct a three-month pilot test. Kolgjini Stables is a Swedish stable…
Diagonal Bio announces that it is exploring financing options
English, IR, MAR, News, RegulatoryDiagonal Bio AB ("Diagonal Bio" or "the Company") today announces that the Board of Directors of the Company has engaged financial and legal advisors and decided to explore potential financing alternatives to secure the Company’s ongoing…

